Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.71 EUR | -0.46% | +8.55% | -1.49% |
Sales 2024 * | 60.13B 55.88B 4,794B | Sales 2025 * | 62.49B 58.07B 4,981B | Capitalization | 157B 146B 12,553B |
---|---|---|---|---|---|
Net income 2024 * | 7.18B 6.68B 573B | Net income 2025 * | 10.17B 9.45B 810B | EV / Sales 2024 * | 3.51 x |
Net Debt 2024 * | 53.77B 49.96B 4,286B | Net Debt 2025 * | 42.59B 39.58B 3,395B | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
14
x | Employees | 88,000 |
Yield 2024 * |
6.09% | Yield 2025 * |
6.19% | Free-Float | 59.09% |
Latest transcript on Pfizer, Inc.
1 day | -0.46% | ||
1 week | +8.55% | ||
Current month | +7.17% | ||
1 month | +0.47% | ||
3 months | +3.46% | ||
6 months | -10.42% | ||
Current year | -1.49% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 31/12/92 |
David Denton
DFI | Director of Finance/CFO | 59 | 01/05/22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 31/03/20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 22/02/17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 26/09/13 |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 25.6 | -0.89% | 6,476 |
02/05/24 | 25.83 | +7.67% | 11,652 |
30/04/24 | 23.99 | +0.38% | 3,894 |
29/04/24 | 23.9 | +0.38% | 11,246 |
26/04/24 | 23.81 | +0.53% | 6,979 |
Delayed Quote Deutsche Boerse AG, May 03, 2024 at 07:47 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
+8.08% | 149B |
- Stock Market
- Equities
- PFE Stock
- PFE Stock